Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 12, 2010, Pages 2673-2677

  Van Der Graaf, Anouk ^a   Vissers, Maud N ^a   Gaudet, Daniel ^b   Brisson, Diane ^b   Sivapalaratnam, Suthesh ^a   Roseboom, Tessa J ^a   Jansen, Angelique C M ^a   Kastelein, John J P ^a   Hutten, Barbara A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cardiovascular disease prevention; familial hypercholesterolemia; lipids

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CANADA; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; DYSLIPIDEMIA; EXTRACHROMOSOMAL INHERITANCE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MOTHER; NETHERLANDS; PRIORITY JOURNAL; PROGENY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPID METABOLISM; MALE; MIDDLE AGED; NETHERLANDS; PEDIGREE; PHENOTYPE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; QUEBEC; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 78650352422     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.209064     Document Type: Article

References (27)

1. Brown MS, Goldstein JL. Receptor-mediated control of cholesterol metabolism. Science. 1976;191:150-154.
2. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management: Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis. 1999;142: 105-112.
3. Henck JW, Craft WR, Black A, Colgin J, Anderson JA. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. Toxicol Sci. 1998;41:88-99.
4. Kyle PM. Drugs and the fetus. Curr Opin Obstet Gynecol. 2006;18: 93-99.
5. Amundsen AL, Khoury J, Iversen PO, Bergei C, Ose L, Tonstad S, Retterstol K. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis. 2006;189:451-457.
6. Woollett LA. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr. 2005;82:1155-1161.
7. Yoshida S, Wada Y. Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J Lipid Res. 2005;46:2168-2174.
8. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680-2690.
9. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. BMJ. 1993;307: 1524-1527.
10. Roseboom TJ, Van Der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Bleker OP. Plasma lipid profiles in adults after prenatal exposure to the Dutch famine. Am J Clin Nutr. 2000;72:1101-1106.
11. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gesta-tional diabetes mellitus. Pediatrics. 2005;115:e290-e296.
12. Napoli C, Palinski W. Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications. Eur Heart J. 2001;22:4-9.
13. Elahi MM, Cagampang FR, Anthony FW, Curzen N, Ohri SK, Hanson MA. Statin treatment in hypercholesterolemic pregnant mice reduces cardiovascular risk factors in their offspring. Hypertension. 2008;51: 939-944.
14. Alkemade FE, Gittenberger-de Groot AC, Schiel AE, VanMunsteren JC, Hogers B, Van Vliet LS, Poelmann RE, Havekes LM, Willems Van Dijk K, DeRuiter MC. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life. Arte-rioscler Thromb Vasc Biol. 2007;27:2228-2235.
15. Goharkhay N, Tamayo EH, Yin H, Hankins GD, Saade GR, Longo M. Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring. Am J Obstet Gynecol. 2008;199(3): 273-276.
16. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999;354:1234-1241.
17. Marseille-Tremblay C, Ethier-Chiasson M, Forest JC, Giguere Y, Masse A, Mounier C, Lafond J. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev. 2008;75:1054-1062.
18. Vuorio AF, Miettinen TA, Turtola H, Oksanen H, Gylling H. Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns. J Lab Clin Med. 2002;140:35-42.
19. Jansen AC, Van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, Liem AH, Van Lennep HW, Sijbrands EJ, Kastelein JJ. The contribution of classical risk factors to cardiovascular disease in familial hypercho-lesterolaemia: data in 2400 patients. J Intern Med. 2004;256:482-490.
20. Reymer PW, Groenemeyer BE, Van de Burg R, Kastelein JJ. Apoli-poprotein E genotyping on agarose gels. Clin Chem. 1995;41:1046-1047.
21. Goharkhay N, Sbrana E, Gamble PK, Tamayo EH, Betancourt A, Vil-larreal K, Hankins GD, Saade GR, Longo M. Characterization of a murine model of fetal programming of atherosclerosis. Am J Obstet Gynecol. 2007;197:416-425.
22. Akcakus M, Koklu E, Baykan A, Yikilmaz A, Coskun A, Gunes T, Kurtoglu S, Narin N. Macrosomic newborns of diabetic mothers are associated with increased aortic intima-media thickness and lipid concentrations. Horm Res. 2007;67:277-283.
23. Tonstad S, Joakimsen O, Leren TP, Ose L. Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercho-lesterolaemia? Acta Paediatr. 2000;89:1490-1492.
24. Descamps OS, Bruniaux M, Guilmot PF, Tonglet R, Heller FR. Lipoprotein concentrations in newborns are associated with allelic variations in their mothers. Atherosclerosis. 2004;172:287-298.
25. Deruiter MC, Alkemade FE, Gittenberger-de Groot AC, Poelmann RE, Havekes LM, Van Dijk KW. Maternal transmission of risk for atherosclerosis. Curr Opin Lipidol. 2008;19:333-337.
26. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321:641-646.
27. Slack J. Risks of ischaemic heart-disease in familial hyperlipopro-teinaemic states. Lancet. 1969 December 27;2(7635):1380-1382.